Fundraising Fox
Sander Slootweg
InvestorCo-founder & Managing Partner at Forbion
Netherlands
Writes $100K – $5M checks · typically $1.5M
Find your path to Sander
Sign up to see every warm intro you have to Sander
- Paths you didn't know you had: your email and LinkedIn already hold routes to Sander. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Sander Slootweg is Managing Partner at Forbion, which he co-founded in 2006 after co-founding ABN AMRO Capital/Life Sciences in 2000. His earlier roles at ABN AMRO Bank included buy-out and growth equity investing, equity capital markets syndications, and financial institutions relationship management for Latin America. He holds degrees in Business and Financial Economics from the Free University of Amsterdam and in Business Administration from Nyenrode University, and focuses on life sciences investing.
Invests in
Biotech
Investments
Board seats
AzafarosForbion European Acquisition CorpNewAmsterdam PharmaNorthSea TherapeuticsReplimuneuniQure
Investor
Sources: the firm's website · curated public sources.
Colleagues at Forbion
Frequently asked questions
- Who is Sander Slootweg?
- Sander Slootweg is Managing Partner at Forbion, which he co-founded in 2006 after co-founding ABN AMRO Capital/Life Sciences in 2000. His earlier roles at ABN AMRO Bank included buy-out and growth equity investing, equity capital markets syndications, and financial institutions relationship management for Latin America. He holds degrees in Business and Financial Economics from the Free University of Amsterdam and in Business Administration from Nyenrode University, and focuses on life sciences investing.
- Where does Sander Slootweg work?
- Sander Slootweg is Co-founder & Managing Partner at Forbion.
- What does Sander Slootweg invest in?
- Sander Slootweg invests in Biotech.
- What check size does Sander Slootweg write?
- Sander Slootweg typically writes checks of $100K – $5M.
- What boards does Sander Slootweg sit on?
- Sander Slootweg holds tracked board seats at Azafaros, Forbion European Acquisition Corp, NewAmsterdam Pharma, NorthSea Therapeutics, Replimune, uniQure.
- What companies has Sander Slootweg invested in?
- Investments tracked here include Azafaros, NewAmsterdam Pharma, Northsea Therapeutics, Oxyrane UK.
About this profile. Compiled from public sources — Forbion's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights